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Abstract 
Purpose: To explore how raters combine constituent components of HCR-20 risk assessment 
for inpatient aggression, and how relevant they rate the tool for different diagnostic and 
demographic groups.  
Design/methodology/approach: A cross-sectional survey design was used. N=45 mental 
health clinicians working in a secure hospital responded to an online survey about their risk 
assessment practice.  
Findings: HCR-20 Historical and Clinical sub-scales were rated the most relevant to violence 
prediction but four of the five items rated most relevant were Historical items. A recent 
history of violence was rated more important for risk formulation than Historical and Risk 
management items, but not more important than Clinical items. While almost all respondents 
believed predictive accuracy would differ by gender, the tool was rated similarly in terms of 
its relevance for their client group by people working with men and women respectively. 
Research limitations/ implications: This was an exploratory survey and results should be 
verified using larger samples.  
Practical implications: Clinicians judge recent violence and Clinical items most important 
in inpatient violence risk assessment but may over-value historical factors. They believe that 
recent violent behaviour is important in risk formulation; however, while recent violence is 
an important predictor of future violence, the role it should play in SPJ schemes is poorly 
codified. 
Social implications: It is important that risk assessment is accurate in order to both protect 
the public and to protect patients from overly lengthy and restrictive detention.  
Originality/ value: Despite the vast number of studies examining the predictive validity of 
tools like HCR-20 very little research has examined the actual processes and decision-making 
behind formulation in clinical practice.  
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Background 
Structured professional judgement (SPJ) approaches are recommended for the assessment of 
risk for violence among criminal justice and mental health populations (National Institute for 
Mental Health in England, 2004). SPJ tools, including the Historical Clinical Risk 
management – 20 (HCR-20; Webster, Douglas, Eaves, & Hart, 1997) and the Short Term 
Assessment of Risk and Treatability (START; Webster, Martin, Brink, Nicholls, & 
Desmarais, 2009), include schedules of empirically grounded risk factors whose presence, 
partial presence, or absence raters are required to determine. 
 SPJ tools differ from actuarial schemes in which a numerical score is calculated, compared 
with data from validation samples, and used to determine a non-discretionary risk-level 
assignation according to predetermined cut-off scores. In contrast, SPJ relies on an 
idiographic reading of the individual patient’s risk factor assessment, together with other 
relevant considerations, before a final risk level (usually high, medium or low) is assigned at 
the raters’ discretion and incorporating their own clinical expertise. While SPJ tools can be 
used actuarially for research purposes by summing risk schedule items this is not 
recommended for clinical practice (Webster et al., 1997) and cut-off scores are not provided 
since the total number of present risk factors is not considered to be the sole determinant of 
risk (Hart & Logan, 2011). No detailed exposition of the weight or content that should be 
placed on various components of the SPJ assessment is provided; indeed, overly directive 
advice would be contrary to the spirit of the SPJ approach (Hart & Logan, 2011). 
Nevertheless, SPJ tool developers have become increasingly expansive about the 
processraters should follow when formulating risk estimates. For example, while somewhat 
rudimentary advice was offered in the manual for HCR-20 version 2 (Webster et al., 1997), 
developments in version 3 (Douglas, Hart, Webster, & Belfrage, 2013) are more detailed. A 
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seven-step procedure recommended: i) information gathering; ii) establishing presence of risk 
factors; iii) determining relevance of risk factors; iv) undertaking risk formulation; v) 
scenario planning; and vi) developing a management plan; vii) finally, the overall summary 
judgement is made using the information gathered and considerations made during stages 1 to 
6. Studies of the predictive efficacy of the HCR-20 for inpatient aggression show that, while 
a score calculated actuarially is significantly predictive of violence, it fares less well than the 
overall final judgement (O'Shea, Mitchell, Picchioni, & Dickens, 2013). Similarly, the 
START violence risk estimate also has incremental predictive validity over the risk scale 
score (O'Shea, Picchioni, & Dickens, 2016). This suggests that the process of formulation 
described above and/or other elements of arriving at the overall final judgement adds 
predictive value and, accordingly, examination of these phenomena has the potential to 
inform risk assessment in practice. 
Despite the potential value of understanding clinicians’ SPJ ratings-related practice, little is 
known empirically about how they arrive at their final risk judgement. While trained raters 
will be aware of the recommended procedure of arriving at a final judgement, it is not known 
whether this is adhered to; indeed the developers of HCR-20 version 3 acknowledge that “not 
all steps will be done by all evaluators or in all cases” (Douglas, Hart, Webster, Belfrage, 
Guy, & Wilson, 2014, p. 100). Additionally, since SPJ schemes explicitly value the raters’ 
individual expertise, it is self-evident that their views of different elements of the assessment 
will influence their rating for good or bad. We recently conducted a study (O’Shea & 
Dickens, 2016) to explore the contribution of risk assessment components to summary 
judgements, and of the contribution of those components and summary judgements, to the 
prediction of risk outcomes using clinically generated risk assessment data from the START. 
We found that raters’ violence risk estimate was predicted by two START components: 
lifetime history of violence, and the vulnerabilities scale score (i.e., summed presence of 
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items included on the tool’s risk schedule). However, the best predictor of actual violent 
outcomes, with incremental predictive ability above the START components, was our self-
developed heuristic indicator representing the presence of violence in the 3-month period 
prior to assessment. This risk factor is not identified in the START manual for consideration. 
We believe that, in this instance, raters were over-estimating the importance of risk factors 
contained in the START vulnerabilities scale, and the lifetime history of violence, in the 
prediction of short-term risk for violence. If this is the case then a rating of increased risk in 
the absence of recent history of risk, and the subsequent enactment of restrictive management 
procedures based on that rating, may be unjustified and thus unethical. This provides further 
impetus to examine how clinicians formulate risk estimates in practice since they may not be 
using all the available information in an optimal manner.  A further reason for studying how 
clinicians make risk estimates, and the processes behind those decisions, lies in the relevance 
or otherwise of the tool and its’ components to the individual case at hand. For example, we 
have previously ascertained that the HCR-20 does not perform equally across demographic 
and clinical groups (O'Shea, Picchioni, Mason, Sugarman, & Dickens, 2014) for prediction of 
inpatient aggression, but the extent to which assessors believe that a tool is relevant to their 
clinical population when it differs significantly from the validation population is not known. 
Since we were collecting data from different professional groups we also examined whether 
professional background was associated with any systematic differences in terms of 
perceptions of elements of the HCR-20. We have conducted an exploratory survey study of 
clinicians’ views of the HCR-20 in order to explore these issues. The specific aims were to: 
• Ascertain which elements of the HCR-20 clinicians believe are most important in risk 
assessment for inpatient violence and compare this to findings from previous studies of 
predictive accuracy.  
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• Determine whether rating clinicians believe that HCR-20 is equally valid for different 
populations, and whether they believe it is valid for the population(s) with which they apply 
the tool in practice. 
• Determine whether professional groups differ in terms of their perceptions of performance 
of elements of the HCR-20. 
• Ascertain whether clinicians believe there are risk factors for violence in their clinical 
populations that are not covered in the HCR-20 schedule.  
Method 
Setting and participants 
The study was conducted across four geographical sites of St Andrew’s, a charitable provider 
of specialist secure inpatient mental health care in England. Potential participants were any 
clinicians with experience of using the HCR-20 for risk assessment. We did not conduct a 
power calculation to inform desirable sample size since i) the study was exploratory, and ii) 
no previous study has used these measures so there was insufficient information to estimate 
power. We aimed for a sample of N=50. 
Design 
A cross-sectional survey design utilising repeated measures (ratings of clinicians' perceptions 
of the value of each of the HCR-20's subscales; and ratings of HCR-20 accuracy for different 
demographic and clinically defined groups) and independent group measures (clinicians' 
ratings of HCR-20 accuracy for their own patient group versus ratings of clinicians working 
with other patient groups; ratings of HCR-20 accuracy by professional group). Additionally, 
participants were surveyed about their perceptions of the most and least important HCR-20 
items, and about whether there were risk factors present in their patient group which were not 
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addressed by the HCR-20.  
Procedure 
The study was approved by the Hospital quality assurance team. A questionnaire was hosted 
on the organisation’s intranet site and a link was circulated via email to all qualified 
clinicians informing them of the purpose of the study and inviting participation. The survey 
was available for completion for two weeks and participation was anonymous. 
Measures 
We devised a questionnaire comprising items relevant to the study aims (available on request 
from the authors). In addition to items to ascertain the demographic characteristics of 
participants, we asked about the patient group that they worked with in terms of gender and 
diagnostic category (Schizophrenia, Personality disorder, Intellectual disability, Organic/ABI, 
Developmental). Questions about their use of the HCR-20 related to the overall accuracy of 
the tool with their patient group (measured on a scale of 1 to 10); the importance of the 
individual H (Historical), C (Clinical), and R (Risk management) scales in generating an 
overall risk estimate; and the importance of a lifetime history of violence and of recent (e.g., 
past 3-month) violence in formulating an overall risk estimate. We also asked participants to 
indicate whether they believed the HCR-20 was likely to be a more, less, or similarly 
accurate predictor of violence for gender and diagnostic groups other than those with which 
they currently worked. Finally, we asked participants to select the five most and five least 
important items in the prediction of violence with their client group. All our questions related 
to version 2 of the HCR-20 (Webster et al., 1997) since that was the version in use in the 
study setting at the time. The HCR-20 version 2 comprises 20 items in three subscales: 
Historical, Clinical, and Risk management (see Table 1). The questionnaire was circulated to 
a multidisciplinary reference group for comment; feedback was gathered and appropriate 
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amendments made.  
>>Insert Table 1 about here<< 
Analysis 
Data were analysed using SPSS Version 22 (IBM SPSS Statistics, 2013). Sample 
characteristics, rating of utility of HCR-20 in non-validation samples, and presence of other 
risk factors for violence were subject to descriptive analyses; comparison of the relative 
importance of elements of HCR-20 assessment was made using one-way ANOVA; similarly, 
significant differences between overall HCR-20 accuracy by staff groups working with 
different groups of patients were made using one way ANOVAs. For analysis of the 
perceptions of different professional groups we collapsed data to two groups (psychiatrists 
n=24 and all others n=21) and analysed using independent samples t-tests or non-parametric 
equivalents where appropriate. 
Results 
In total, N=45 clinicians completed the survey; characteristics of the sample are presented in 
Table 2. In addition, psychiatrists had similar total years experience than all other clinicians 
(M=6.24 ±9.46, vs. M=8.74 ±7.42, P=.95) but reported more years HCR-20 experience 
(Median=5+ years vs. Median=2-5 years, Z=-3.99, P<.001). 
>> Insert Table 2 about here << 
Most relevant HCR-20 subscales 
When asked which HCR-20 subscales were of most relevance to risk assessment with their 
patients the Historical and Clinical subscales were selected as first choice by n=19 
respondents each (42%) with the remainder (n=7; 18%) favouring the risk management 
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items. Similarly, almost 80% also believed that either Historical or Clinical items were the 
second most relevant suite of items, whilst n=37 (82%) believed risk management items to be 
the second or third most relevant. In contrast, when we asked respondents to name the five 
individual HCR-20 items they believed to be most relevant to violence risk assessment, 
Historical items were the clear leaders; four of the five most frequently listed items were 
from the Historical scale ('early maladjustment', 'previous violence', 'major mental illness', 
'young age at first violence'). Of the dynamic clinical and risk management items only the 
clinical item ‘active symptoms of major mental illness’ was in the five most relevant items. 
Of the individual items rated among the five the least important, three were from the 
Historical scale ('psychopathy', 'employment problems', and 'personality disorder'), while one 
item each were drawn from the Clinical (‘lack of insight’) and Risk management 
(‘noncompliance with remediation attempts’) scales. 
One-way ANOVA indicated a statistically significant difference between participants’ ratings 
of the importance of various aspects of the HCR-20 assessment in arriving at a risk estimate 
(F [4, 219] =3.798, P<.01). A Tukey post hoc test revealed that a recent history of violence 
was rated as more important (8.36 ± 1.00) than HCR-20 H items (7.22 ±2.10, P<.05) and R 
items (7.16 ±1.96, P<.01), but not C items (7.53 ± 1.89) or lifetime history of violence (7.87 
±1.27). No other significant differences between ratings were found. 
HCR-20 as a violence predictor for different diagnostic and demographic groups  
Overall, no respondent believed that the HCR-20 was likely to be a better predictor of 
inpatient aggression for diagnostic groups that differed from those mostly used in validation 
samples (see Table 3). For violence prediction among people with intellectual disability or 
developmental conditions most respondents thought the HCR-20 was likely to be a similar or 
poorer performer, while a majority were unsure about how it might perform for people with 
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brain injury or organic conditions. Interestingly, a more polarised response was evident for 
gender: one third of respondents thought HCR-20 was likely to be a better performer for 
women, and just under two thirds a poorer performer; only one respondent estimated similar 
performance. Of those believing it to be a better performer for women, six (40%) worked 
with women, eight (53%) with men, and one (7%) with both. 
Despite clear differences in beliefs about the predictive ability of the HCR-20 in the whole 
sample we found no significant differences in ratings of the accuracy of the HCR-20 when 
we asked respondents about use of the tool with their own patient group. One-way ANOVA 
revealed that the M (SD) rating for those who worked with men was 5.92 (± 2.02); women 
6.29 (± 1.54); both 6.50 (± 1.23); (F (2, 42) = .347, P=.201). M (SD)for those who worked 
primarily with those with schizophrenia was 5.75 (± 1.96); PD 6.50 (± 1.51); ID 5.82 (± 
2.23); Organic 5.00 (± 2.83); Developmental 6.75 (± .71), (F (4, 40) = .783, P=.583). 
>> Insert Table 3 about here << 
Differences in perceptions of the HCR-20 by professional group  
Psychiatrists were not different from other professionals in their ratings of the accuracy of 
HCR-20 for predicting aggression in their own patient group (M=6.28 ± 1.71 vs. M=6.08 ± 
1.84, t=.349, df=40, P=.63). Psychologists and others rated HCR-20 Clinical subscale items 
as more influential on their overall summary judgement than did psychiatrists (M=8.28 ±.96 
vs. M=6.96 ±2.331, t=2.27, df=40, P<.05); there were no other significant differences on the 
influence of the Historical or Risk Management items, nor on the influence of any history of 
violent behaviour or recent aggression. 
Missing risk factors in HCR-20 for violence in different clinical and diagnostic groups 
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Finally, we asked whether respondents felt there were risk factors specific to their clinical 
population that were not included in the HCR-20. Those working with patients with 
developmental disabilities provided the most suggestions (changes to the environment, 
misinterpretation of social norms, communication difficulties/ dysfunction, genetic). Those 
working with patients with intellectual disability suggested risk factors including overly  
restrictive practices, inter-patient conflict, lack of structured activity, lack of availability of 
regular nursing staff, lack of involvement in decision-making, and reliance on pro re nata (as 
required) medication as a management strategy. Those working with brain injured patients 
named frontal lobe problems, temporal lobe problems, sensory impairments, and cognitive 
impairments. Those working with patients with a diagnosis of personality disorder suggested 
ward atmosphere and ward environment.  
Discussion 
While there are numerous studies which demonstrate that the HCR-20 is able to predict 
inpatient aggression with some accuracy (O'Shea et al., 2013) the current study is one of the 
few available in the literature to provide information about the assumptions or beliefs held by 
clinicians who make ratings of risk violence using the tool. Given that rater discretion is 
integral to the SPJ approach there were number of interesting findings worthy of discussion. 
First, our finding that different elements of the HCR-20 risk assessment are rated as poorer 
performers in the prediction of inpatient violence than recent aggression suggests that 
clinicians’ HCR-20 final judgements might be weighted by their knowledge about the 
presence or absence of this behaviour. This contrasts with findings from our previous study 
(O’Shea & Dickens, 2016) using the START where we found that recent aggression prior to 
the risk assessment did not predict an elevated summary judgement for violence. However, 
the same study did suggest that recent aggression was, in fact, the best predictor of actual 
outcome as opposed to a predictor of the final judgement. If the same were true for the HCR- 
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20 then it would suggest that clinicians are correct to rate it as important and, if they do not 
already, should incorporate a recent aggression heuristic – or re-weight an existing one 
appropriately - into their summary judgement formulation. 
HCR-20 Historical, Clinical, and Risk management items were not rated differently from one 
another in terms of overall influence on respondents’ final risk judgement. In contrast, 
respondents identified four Historical scale items in the top five items most likely to be 
relevant to inpatient aggression. This may superficially appear paradoxical; how can one 
simultaneously hold the view that historical items are some of the most important 
determinants of inpatient violence yet not rate them the most important element in the overall 
judgement? However, it may be that clinicians recognise that the Historical items are relevant 
to aggression and rate them accordingly when asked this, but do not assign greater relevance 
to them when formulating overall risk level since, in the current study setting, most patients 
hold multiple Historical scale risk factors (see e.g., O'Shea et al., 2014). Reliance, therefore, 
on these items during formulation of overall risk would likely lead them to rate everyone at 
elevated risk which would not help with prioritisation of resources or identification of risk 
management interventions. Alternatively, clinicians’ rating of the import of the Historical 
scale as a whole may not reflect their rating of a subset of individual items. From this 
perspective it is possible that clinicians really do overvalue the subset of Historical items 
related to early maladjustment, previous violence, major mental illness, and young age at first 
violent episode. Such items are relatively static and not amenable to change through 
intervention. Their contribution in formulating an overall risk judgement is, on the balance 
ofprobabilities, likely to weight that assessment towards stasis. Importantly, if these are seen 
as the most important risk factors for aggression it could lead to a lack of focus on more 
dynamic items which, if successfully addressed, might reduce risk. The HCR-20 version 3 
potentially circumvents this concern by requiring raters to determine the relevance of the risk 
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as well as the presence.  
There were mixed findings regarding the applicability of HCR-20 risk assessment to groups 
who differ substantially from validation populations. No respondents believed that HCR-20, 
when used for diagnostic groups including patients with intellectual or developmental 
disability or organic conditions, outperformed its predictive ability with regard to validation 
samples; a small minority for each diagnostic condition thought it might perform equally, but 
most felt the tool was likely perform more poorly or were unsure. This was reflected in 
respondents working with niche clinical samples naming a number of further risk factors that 
they believed to be important while those working with patients like those in validation 
samples reported fewer. However, about a third of respondents, and two fifths of those 
working with women, thought that the tool might perform better for women than for male 
only validation samples. This is interesting since a study of differential predictive validity 
conducted in the current study setting (O'Shea et al., 2014) demonstrated that the HCR-20 did 
indeed have superior efficacy when applied to women compared to men. In fact, while all but 
one (n=44, 97.7%) respondent expressed that the predictive validity of HCR-20 would likely 
differ between men and women (i.e., would either be better or worse but not the same); 
ratings of the accuracy of HCR-20 for their own client group by clinicians working with men 
and women respectively did not differ significantly. Thus, while subjectively clinicians 
believed that the tool had better predictive ability for one group or the other, clinicians who 
worked with each group rated predictive ability similarly. We suspect the practical value of 
this finding is that those using the tool with women should be reassured that perception of it 
as a relatively inferior performer are possibly misplaced. 
There was only one difference between different professional groups: namely that non-
psychiatrists reported that HCR-20 clinical items had significantly more influence on their 
overall summary judgements than did psychiatrists. This should be interpreted with caution 
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since psychiatrists had significantly more years experience and, as a result, this may be a 
result of experience rather than profession. Nevertheless, it is interesting to find that, 
potentially, there are significantly different ways of formulating a summary judgement. The 
research implication is a need to determine whether the perceived import placed on certain 
aspects leads to a qualitatively or quantitatively different summary judgement; if there is, 
then there is an additional need to investigate whether one method provides a judgement with 
greater predictive accuracy. 
Limitations 
This was a small survey conducted across one provider of specialist secure mental health 
services, including many participants who work with patients for whom the HCR-20 was not 
specifically developed but is used due to a lack of alternative tools. Findings therefore may 
not be generalizable to more mainstream forensic, secure services. The questionnaire was 
developed to answer study aims and did not possess known psychometric properties. 
Participants were self-selecting and may not have been representative of the clinical 
workforce. 
Conclusions 
In practice clinicians may overvalue some HCR-20 historical items when conducting 
violence risk assessment. They appear to appreciate the role that recent violence plays in 
inpatient risk though this is not a formal part of the HCR-20 assessment. Our results suggest 
that clinicians lack confidence in the ability of the HCR-20 to be of optimal value for 
assessment of those with diagnostic conditions outwith its validation samples. As a result, we 
recommend that more development is required in terms of risk assessment for people with 
disorders other than schizophrenia or personality disorder. The picture in terms of its value 
from a gendered perspective is more complex since the perception of inferior performance 
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with women may be misplaced. There is, therefore, a need to test tools developed for women, 
such as the Female Additional Manual (de Vogel, de Vries Robbé, van Kalmthout, & Place, 
2014), to ensure they really do add value. 
 
Implications for practice 
• Clinicians using HCR-20 for violence risk assessment in secure forensic mental health 
settings should remain mindful of, and periodically question, their own assumptions and 
beliefs about the relative value of aspects of HCR-20 assessment. 
• Those working with people with mental health diagnoses that are significantly different 
from HCR-20 validation samples appear knowledgeable about the relative value of the tool 
with those patients and should be supported to supplement assessment with information from 
more appropriate tools where viable. 
• Those working with women should be aware that their belief in the relatively poor 
performance of HCR-20 for that group is not supported either in evidence about actual 
performance, nor in comparative ratings of accuracy for men when compared with clinicians 
who work with men in the current study.   
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Table 1: HCR-20 version 2 items 
Historical items Clinical items Risk management items 
H1 Previous violence C1 Lack of insight R1 Plans lack feasibility 
H2 Young age at first 
incident C2 Negative attitudes R2 Exposure to destabilizers 
H3 Relationship 
instability 
C3 Active symptoms of major 
mental illness R3 Lack of personal support 
H4 Employment 
problems C4 Impulsivity 
R4 Noncompliance with 
remediation attempts 
H5 Substance use 
problems C5 Unresponsive to treatment R5 Stress 
H6 Major mental 
illness     
H7 Psychopathy     
H8 Early 
maladjustment     
H9 Personality disorder     
H10 Prior supervision 
failure   
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Table 2: Sample characteristics (N=45) 
 n (%) 
Profession:  
 Psychiatrist 24 (53.3) 
 Psychologist 18 (40) 
 Nurse 1 (2.2) 
 Other 2 (4.4) 
Patient group gender:  
 Men 25 (55.6) 
 Women 14 (31.1 
 Both 6 (13.3) 
Patient group diagnoses:  
 Schizophrenia 11 (24.4) 
 Personality disorder 9 (20.0) 
 Intellectual disability 4 (8.9) 
 Organic/ABI 2 (4.4) 
 Developmental 8 (17.8) 
 2+ categories 11 (24.4) 
Years experience:  
 <1  1 (2.2) 
 1 to 2 14 (31.1) 
 3 to 5 12 (26.7) 
 >5 17 (37.8) 
 Missing 1 (2.2) 
Years HCR-20 experience:  
 <1 5 (11.1) 
 1 to 2 6 (13.3) 
 3 to 5 13 (28.9) 
 >5 21 (46.7) 
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Table 3: Estimated value of HCR-20 for prediction of inpatient aggression by 
diagnosis/gender relative to validation samples of males with schizophrenia 
personality disorder diagnoses 
HCR-20 for people 
with… 
ID 
n(%) 
Organic/ABI 
n (%) 
Developmental 
n (%) 
Women 
n (%) 
Diagnoses is…
 Better 
 
0 (0) 
 
0 (0) 
 
0 (0) 
 
15 (33.3) 
 Same 15 (33.3) 6 (13.3) 9 (20.0) 1 (2.2) 
 Worse 12 (26.7) 12 (26.7) 15 (33.3) 29 (64.4) 
 Unsure 16 (35.6) 27 (60.0) 17 (37.8) 0 (0) 
 Missing 2 (4.4) 0 (0) 3 (6.7) 0 (0) 
… than for validation samples with schizophrenia and/or personality disorder 
 
